The role of nephrectomy in metastatic renal cell carcinoma in the immuno‐oncology era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of nephrectomy in metastatic renal cell carcinoma in the immuno‐oncology era

Published:2021-05-07 Issue:4 Volume:128 Page:438-439
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Würnschimmel Christoph¹²^ORCID,Nocera Luigi²³,Wenzel Mike²⁴^ORCID,Collà Ruvolo Claudia²⁵^ORCID,Tian Zhe²,Karakiewicz Pierre I.²

Affiliation:

1. Martini‐Klinik Prostate Cancer Center University Hospital Hamburg‐Eppendorf Hamburg Germany

2. Cancer Prognostics and Health Outcomes Unit Division of Urology University of Montréal Health Center Montréal QC Canada

3. Department of Urology and Division of Experimental Oncology URI Urological Research Institute IBCAS San Raffaele Scientific Institute Milan Italy

4. Department of Urology University Hospital Frankfurt Frankfurt am Main Germany

5. Department of Neurosciences, Reproductive Sciences and Odontostomatology University of Naples Federico II Napoli Italy

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15426

Reference5 articles.

1. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial

2. Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

3. Pembrolizumab plus axitinib versus sunitinib as first‐line therapy for advanced renal cell carcinoma (RCC): Updated analysis of KEYNOTE‐426;Soulières D;J Clin Oncol,2020

4. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

5. Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients;Clinical Genitourinary Cancer;2023-10

2. Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis;World Journal of Surgical Oncology;2023-06-22

3. Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity;Urologic Oncology: Seminars and Original Investigations;2022-11

4. IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time;Seminars in Oncology;2022-10

5. A Pathological Complete Response to the Combination of Ipilimumab and Nivolumab in a Patient with Metastatic Renal Cell Carcinoma;Medicina;2022-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3